Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Priority to UY24851ApriorityCriticalpatent/UY24851A1/en
Publication of UY24851A1publicationCriticalpatent/UY24851A1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Nuevos derivados de n-acil-alfa-aminoácido, un procedimiento para su preparación, preparados farmacéuticos que contienen estos compuestos y empleo de estos compuestos en la preparación de composiciones farmacéuticas.Novel n-acyl-alpha-amino acid derivatives, a process for their preparation, pharmaceutical preparations containing these compounds and use of these compounds in the preparation of pharmaceutical compositions.
UY24851A1998-01-211998-01-21
DERIVATIVES OF N-ACIL-ALPHA-AMINATED ACIDS
UY24851A1
(en)
A SALT OF A COMPOUND DERIVED FROM CARBOXYLLIC NAFTIRIDINE ACID, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE TO PREPARE IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
DERIVATIVES OF FENIL-4-TIAZOLES SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND DERIVATIVES DEFENIL-4-TIAZOLES SUBSTITUTED USED IN SUCH PROCEDURE.
2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as metalloproteinase inhibitors, process for their preparation and pharmaceutical compositions containing them